Amyris (AMRSQ) Aktie Kurs

Amyris Kurs

NASDAQ·LUKKET
0,00
​
Markedet lukket

De seneste 17 år voksede Amyriss omsætning med 31,7 % årligt og nåede 269,85 Mio. USD. For Amyris er nettoavance på -195,9 % op i forhold til -350,8 % for et par år siden.

Amyris aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Amyris aktie og aktieanalyse

Amyris Inc. er et amerikansk selskab, der specialiserer sig i produktionen af bæredygtige produkter. Selskabet blev grundlagt i 2003 og har hovedkvarter i Emeryville, Californien. Det har til formål at fremme bæredygtighed i hverdagen og reducere afhængigheden af fossile brændstoffer. Amyris' forretningsmodel er baseret på opdagelsen og udviklingen af biologiske mikroorganismer, der kan omdanne sukkerarter og andre kulhydrater til værdifulde produkter såsom brændstoffer, kemikalier og smagsstoffer. Denne teknologi, kendt som syntetisk biologi, blev først anvendt til produktionen af artemisinin, som bruges mod malaria. Med tiden har Amyris udvidet sin portefølje og specialiseret sig i produktionen af bæredygtige produkter til kosmetik-, biofuel-, fødevare- og kemikalieindustrien. Nogle af de ledende produkter inkluderer Biosolve, en miljøvenlig opløsningsmiddel til industriel brug, Neossance, en plante-baseret fugtgivende ingrediens til kosmetikindustrien, og Biofene, et bio-baseret brændstof. For at producere sine produkter har selskabet indgået partnerskaber med forskellige organisationer verden over. Det har f.eks. indgået samarbejde med Total, et fransk olie- og gasselskab, om at etablere joint ventures til produktion af biofuels. Amyris har også udvidet sin forretning ved at udvikle en platform for syntetisk biologi, der gør det muligt for andre aktører i branchen at udvikle skræddersyede organismer til produktionsprocesser. Denne nye forretningsmodel har bragt selskabet ind på nye markeder såsom medicinal- og energisektoren. I 2020 stillede COVID-19-pandemien udfordringer for selskabet, da efterspørgslen på nogle produkter faldt. Som reaktion skiftede Amyris produktionen over til desinfektionsmidler for at imødekomme den stigende efterspørgsel efter disse produkter. Samlet set har Amyris blevet et førende selskab inden for bæredygtig produktion og er engageret i at fremme innovationer inden for syntetisk biologi for at skabe en positiv effekt på miljøet.

Hyppigt stillede spørgsmål om Amyris-aktien

Amyris Inc is a leading biotechnology company focused on sustainable ingredients for various industries. Their business model revolves around the production and commercialization of high-performance sustainable products. With a strong emphasis on innovation, Amyris utilizes its proprietary synthetic biology platform to engineer microbes and produce sustainable alternatives to petroleum-derived chemicals. These include renewable ingredients for cosmetics, fragrances, flavors, and nutraceuticals, as well as renewable feedstocks for the production of renewable diesel and jet fuels. By enabling the transition to a more sustainable economy, Amyris Inc aims to deliver environmental benefits while providing quality products to its customers.

Amyris Inc is primarily active in the renewable chemicals and sustainable fuels industries.

The main competitors of Amyris Inc in the market are Evolva Holding SA, Synthetic Genomics Inc, and Intrexon Corporation.

Amyris Inc. is a leading biotechnology company known for its sustainable solutions in the fields of health and wellness, clean beauty, and renewable chemicals. Founded in 2003, Amyris has a rich history marked by its commitment to advancements in synthetic biology. The company's groundbreaking research has enabled the production of a wide range of innovative products, including sustainable ingredients, fragrances, and high-performance materials. Amyris has collaborated with numerous partners and has expanded its global presence, ensuring the adoption of its renewable solutions worldwide. With a strong focus on environmental and societal well-being, Amyris Inc. continues to revolutionize industries through sustainable, nature-inspired innovations.

Amyris Inc has achieved several significant milestones in its trajectory. Notably, the company successfully developed and commercialized its proprietary yeast strain technology, enabling the production of high-value molecules more sustainably. Amyris Inc also established strategic partnerships with various global leaders, expanding its product portfolio and market reach. Additionally, the company made remarkable progress in the renewable energy sector, delivering renewable diesel and jet fuel solutions. Amyris Inc's commitment to sustainability and innovation has garnered accolades, including recognition as a Fast Company Most Innovative Company and a World Economic Forum Technology Pioneer. The company's continuous growth and advancements solidify its position as an industry leader in sustainable solutions.

Amyris Inc is primarily present in countries and regions across the globe, including the United States, Brazil, Europe, and Asia.

Amyris Inc represents a set of core values and corporate philosophy that drive its business operations. The company is committed to delivering sustainable solutions through its advanced biotechnology platform. Amyris focuses on providing renewable products across various industries, including clean beauty, flavors, fragrances, and sweeteners. With an emphasis on innovation, Amyris strives to create high-performance products, enhancing the quality of life while minimizing the environmental impact. The company's dedication to scientific excellence, integrity, and social responsibility enables Amyris to fulfill its mission of positively transforming the world. Amyris Inc consistently pursues its goal of sustainable development and improving global resource efficiency through innovative biotechnology solutions.

8 analytikere vurderer i øjeblikket Amyris-aktien: 0 anbefaler køb, 3 hold og 5 salg.

Omregnet til den aktuelle valutakurs handles Amyris-aktien til 0,00 EUR (0,00 USD).

Amyris-aktien (AMRSQ) er noteret på 5 børser, herunder: NASDAQ (AMRS), SIX (Zürich) (3A01.SW), Frankfurt (3A01.F), München (3A01.MU), Düsseldorf (3A01.DU).

Amyris Inc. is an American biotechnology company based in Emeryville, California. Founded in 2003, the company specializes in the development and production of molecules that can serve as the basis for a variety of products, particularly in the cosmetics, skincare, body and hair care, perfume, and fragrance industries. Amyris Inc.'s business model is based on the use of innovative biotechnology platforms for the construction and optimization of microorganisms capable of producing specific molecules, such as essential oils, fats and waxes, sugars, flavors, and other compounds, from sustainable raw materials. The company's focus is on producing molecules from renewable resources such as sugarcane, corn, cellulose, and other bio-based materials. The molecules produced by Amyris are used either directly as end products or as ingredients in other products. Amyris has several divisions, including "Ingredients," "Cosmetics & Personal Care," "Fragrances & Flavors," and "Sweeteners & Nutraceuticals." In the "Ingredients" division, the company produces a variety of molecules that can be used as starting materials for the production of cosmetics and personal care products, cleaning agents, lubricants, and other products. Examples of products include squalene, hyaluronic acid, vitamin E, ferulic acid, caprylic/capric triglycerides, and others. In the "Cosmetics & Personal Care" division, Amyris also offers its own skincare, body, and hair care products based on sustainable, organic ingredients. These include nourishing facial oils, moisturizers, cleansers, shampoos, conditioners, and others. In the "Fragrances & Flavors" division, Amyris produces essential oils, flavors, and fragrances that are used in a variety of applications, including perfumes, room fragrances, scented candles, and aromatherapy products. Key products include lavender oil, cinnamon bark oil, lemon oil, vanillin, and others. Finally, Amyris also offers products in the "Sweeteners & Nutraceuticals" category, including plant-based sweeteners such as rebaudioside A and others, as well as dietary supplements based on omega-3 fatty acids, vitamin D3, and other ingredients. Amyris Inc.'s business model is based on the use of innovative biotechnology platforms for the development and production of molecules that can be used as raw materials for a variety of products. By using sustainable raw materials and producing molecules in an environmentally friendly way, the company has established itself as a pioneer in sustainable chemistry. With a wide range of products and a strong presence in global markets, Amyris Inc. is well positioned to continue growing in the coming years and promote awareness of sustainable innovations in the chemical industry.

Omsætningen kan for øjeblikket ikke beregnes for Amyris.

Overskuddet kan for øjeblikket ikke beregnes for Amyris.

P/E-forholdet kan ikke beregnes for Amyris i øjeblikket.

P/S-forholdet kan ikke beregnes for Amyris i øjeblikket.

AlleAktien-kvalitetsscore for Amyris er 8/10.

ISIN for Amyris er US03236M2008. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Amyris er A2DS41. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Amyris er AMRSQ. Tickersymbolet bruges til at handle Amyris-aktier på børsen.

Fair værdiTerminal
0,00 USD
Over-/underværdieringTerminal
Fair værdieret
Industri
Kemikalier
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
453.524,37 USD
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Hjemmeside amyris.com
Land
Valuta
USD
Børsintroduktion
28. sep. 2010
ISIN
US03236M2008
CUSIP
03236M200
SEDOL
BF0FLW8
Markedsværdi
52-ugers interval
AAQS
8 / 10
PEG-forhold
—
P/E-forhold
P/Ee 2023
—
P/Ee 2024
—
P/Ee 2025
-0,01
P/Ee 2026
—
P/Ee 2027
—
P/S
P/Se
0,00
EV/EBIT
—
K/B-forhold
0,00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-183,16 %
Sidst opdateret 21. nov. 2026, 01.48

Amyris Peer Group

Amyris Ticker

DÜSSELDORF · 3A01.DUFRANKFURT · 3A01.FMÜNCHEN · 3A01.MUNASDAQ · AMRSSIX · 3A01.SW

Amyris FIGI

AMRSQ:US · BBG000DW5XK4AMRSQ:PQ · BBG000DW75P8AMRSQ:UV · BBG000DW76853A01:GR · BBG0016VVS153A01:GS · BBG0016VVS513A01:GB · BBG0016VVS79AMRSEUR:EO · BBG00C0L7JL4AMRSEUR:XH · BBG00C0L7JW2AMRSEUR:XF · BBG00C0L7K04AMRSEUR:XE · BBG00C0L7K40AMRSEUR:XJ · BBG00C0L7K68AMRSEUR:XL · BBG00C0L7K86

Alle fundamentale data om Amyris i deep dive

Vores aktieanalyse af Amyris-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Amyris. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: